PUK22 COMPARISON OF THE PRO ENDPOINTS FOUND IN LABELING CLAIMES OF URINARY INCONTINENCE DRUGS WITH THOSE RECOMMENDED BY THE CORRESPONDING EMEA NOTE FOR GUIDANCE
Nov 1, 2006, 00:00 AM
10.1016/S1098-3015(10)63789-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)63789-8/fulltext
Section Title :
Section Order :
642
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63789-8&doi=10.1016/S1098-3015(10)63789-8